Ye Won Jeon

TL;DR: The results suggest that MSD-SCT using Flu/lower-dose Cy/ATG may be a feasible first-line treatment even in older patients with SAA, and may overcome the negative effects of age.

TL;DR: It is found that unfavorable CBF-AML can be defined with risk stratification using cytogenetic and molecular studies, and a careful risk-adapted treatment approach using frontline transplantation with novel therapies should be evaluated for this particular risk subgroup.

TL;DR: The synergistic anti-tumor effect of the celecoxib and luteolin combination treatment in different four breast cancer cell lines is demonstrated, thus introducing the possibility of this combination as a new treatment modality.

TL;DR: Lobectomy plus isthmusectomy may be optimal for early-stage, node-negative papillary thyroid carcinoma originating in the isthmus for tumors ≤1 cm; total thyroidectomy might be better for tumors >1 cm.

TL;DR: It is suggested that weight gain after adjuvant TAC chemotherapy is common in Korean women with breast cancer, and in contrast to previous Western studies, weight gain did not appear to be sustained, and there was no relationship between weight gain and poor RFS.